SES - Delayed Quote USD

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (T14.SI)

Compare
2.4700 +0.0100 (+0.41%)
At close: 5:06 PM GMT+8

Research Analysis

Revenue vs. Earnings

Revenue 1.98B
Earnings 328.86M
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----44
Avg. Estimate 000.210.26
Low Estimate 000.210.25
High Estimate 000.220.27
Year Ago EPS ----0.180.21

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----44
Avg. Estimate ----1.24B1.36B
Low Estimate ----1.23B1.33B
High Estimate ----1.25B1.4B
Year Ago Sales ----1.13B1.24B
Sales Growth (year/est) ----9.20%10.00%

Earnings History

CURRENCY IN USD
EPS Est. --
EPS Actual --
Difference --
Surprise % --

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate 000.210.26
7 Days Ago 000.210.26
30 Days Ago 000.210.26
60 Days Ago 000.220.26
90 Days Ago 000.210.26

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD T14.SIIndustrySectorS&P 500
Current Qtr. ------3.10%
Next Qtr. ------8.00%
Current Year 16.70%----2.30%
Next Year 23.80%----13.20%
Next 5 Years (per annum) ------11.85%
Past 5 Years (per annum) 9.10%------

Related Tickers